- Home
- SYBX vs KRKR Comparison
SYBX vs KRKR Comparison
Compare SYBX & KRKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SYBX
- KRKR
- Stock Information
- Founded
- SYBX N/A
- KRKR 2010
- Country
- SYBX United States
- KRKR China
- Employees
- SYBX N/A
- KRKR N/A
- Industry
- SYBX Biotechnology: Pharmaceutical Preparations
- KRKR Business Services
- Sector
- SYBX Health Care
- KRKR Consumer Discretionary
- Exchange
- SYBX Nasdaq
- KRKR Nasdaq
- Market Cap
- SYBX 13.6M
- KRKR 11.7M
- IPO Year
- SYBX N/A
- KRKR 2019
- Fundamental
- Price
- SYBX $1.20
- KRKR $6.10
- Analyst Decision
- SYBX
- KRKR
- Analyst Count
- SYBX 0
- KRKR 0
- Target Price
- SYBX N/A
- KRKR N/A
- AVG Volume (30 Days)
- SYBX 6.9K
- KRKR 2.6K
- Earning Date
- SYBX 08-07-2025
- KRKR 09-03-2025
- Dividend Yield
- SYBX N/A
- KRKR N/A
- EPS Growth
- SYBX N/A
- KRKR N/A
- EPS
- SYBX 0.21
- KRKR N/A
- Revenue
- SYBX N/A
- KRKR $31,657,328.00
- Revenue This Year
- SYBX N/A
- KRKR $182.55
- Revenue Next Year
- SYBX N/A
- KRKR N/A
- P/E Ratio
- SYBX $5.92
- KRKR N/A
- Revenue Growth
- SYBX N/A
- KRKR N/A
- 52 Week Low
- SYBX $0.90
- KRKR $2.76
- 52 Week High
- SYBX $1.88
- KRKR $12.99
- Technical
- Relative Strength Index (RSI)
- SYBX 54.75
- KRKR 47.72
- Support Level
- SYBX $1.18
- KRKR $5.58
- Resistance Level
- SYBX $1.27
- KRKR $5.65
- Average True Range (ATR)
- SYBX 0.05
- KRKR 0.08
- MACD
- SYBX -0.00
- KRKR -0.04
- Stochastic Oscillator
- SYBX 58.33
- KRKR 33.73
About SYBX Synlogic Inc.
Synlogic Inc is a biopharmaceutical company focuses on rare metabolic disorders, with a lead program in phenylketonuria (PKU) and homocystinuria (HCU). The company's pipeline includes therapeutics for enteric hyperoxaluria, gout, and cystinuria. Using a proprietary approach, the company engineer GI-restricted, oral medicines from well-characterized probiotics. These drug candidates target specific biological pathways, leveraging Escherichia coli Nissle 1917 for consistency and safety. Engineered to be non-colonizing and reversible, the company offer oral administration, simplifying shipping and storage. The company operates in one segment-discovery and development of Synthetic Biotics-pioneering transformative treatments for serious diseases.
About KRKR 36Kr Holdings Inc.
36KR Holdings Inc is a holding company and conducts its business mainly through its subsidiaries, a VIE, and subsidiaries of the VIE. The Group is engaging in providing content and business services to new economy participants in the PRC. Its content production process includes content creation, content editing, screening and monitoring, and content distribution. The Group mainly generates revenues from providing online advertising services, enterprise value-added services, and subscription services. The Group's principal operations and geographic markets are substantially located in PRC.